Family acceptability of school-based echocardiographic screening for rheumatic heart disease in a high-risk population in New Zealand

Journal of Paediatrics and Child Health

Volumn 51, Issue 7, 2015, Pages 682-688

  Perelini, Fiona ^a   Blair, Nikki ^a   Wilson, Nigel ^a   Farrell, Alan ^a   Aitken, Andrew ^b  

^a WELLINGTON HOSPITAL   (New Zealand)

^b STARSHIP CHILDREN S HOSPITAL   (New Zealand)

Author keywords

echocardiogram screening; paediatrics; rheumatic fever; rheumatic heart disease

Indexed keywords

ADOLESCENT; ATTITUDE TO HEALTH; CHILD; ECHOGRAPHY; FEMALE; FOLLOW UP; HEALTH CARE SURVEY; HUMAN; MALE; MASS SCREENING; NEW ZEALAND; PROCEDURES; QUESTIONNAIRE; RETROSPECTIVE STUDY; RHEUMATIC HEART DISEASE; SCHOOL HEALTH SERVICE;

ADOLESCENT; ATTITUDE TO HEALTH; CHILD; FEMALE; FOLLOW-UP STUDIES; HEALTH CARE SURVEYS; HUMANS; MALE; MASS SCREENING; NEW ZEALAND; RETROSPECTIVE STUDIES; RHEUMATIC HEART DISEASE; SCHOOL HEALTH SERVICES; SURVEYS AND QUESTIONNAIRES;

EID: 84934438002     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/jpc.12829     Document Type: Article

References (25)

1. Milne RJ, Lennon DR, Stewart JM, Vander Hoorn S, Scuffham PA,. Incidence of acute rheumatic fever in New Zealand children and youth. J. Paediatr. Child Health 2012; 48: 685-691.
2. New Zealand Heart Foundation. New Zealand Guidelines for Rheumatic Fever 1: Diagnosis, Management and Secondary Prevention. Auckland, 2006. Available from: http://www.heartfoundation.org.nz/files/Rheumatic%20fever%20guideline%201.pdf [accessed 5 March 2012].
3. Malcolm J, Ball S, Beharry J, et al. Tautoko rheumatic hearts: to support those with rheumatic hearts, public health needs innovation, collaboration and evaluation. In:, Zander A, Came H, eds. Proceedings of the 2013 Public Health Association Conference. Auckland, New Zealand: Public Health Association, 2013; 107-112.
4. Manyemba J, Mayosi BM,. Penicillin for secondary prevention of rheumatic fever. Cochrane Database Syst. Rev. 2002; (3): CD002227.
5. National Advisory Committee on Health and Disability. Screening to Improve Health in New Zealand: Criteria to Assess Screening Programmes 2003: [1-49]. 2003. Available from: http://nhc.health.govt.nz/ [accessed 14 January 2013].
6. Cramp G, Stonehouse M, Webb R, Webb R, Chaffey-Aupouri G, Wilson N,. Undetected rheumatic heart disease revealed using portable echocardiography in a population of school students in Tairawhiti, New Zealand. N. Z. Med. J. 2012; 125: 53-64.
7. Webb RH, Wilson NJ, Lennon DR, et al. Optimising echocardiographic screening for rheumatic heart disease in New Zealand: not all valve disease is rheumatic. Cardiol. Young 2011; 21: 436-443.
8. Carapetis JR, Hardy M, Fakakovikaetau T, et al. Evaluation of a screening protocol using auscultation and portable echocardiography to detect asymptomatic rheumatic heart disease in Tongan schoolchildren. Nat. Clin. Pract. Cardiovasc. Med. 2008; 5: 411-417.
9. Marijon E, Ou P, Celermajer DS, et al. Prevalence of rheumatic heart disease detected by echocardiographic screening. N. Engl. J. Med. 2007; 357: 470-476.
10. Remenyi B, Wilson N, Steer A, et al. World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease-an evidence-based guideline. Nat. Rev. Cardiol. 2012; 9: 297-309.
11. Zuhlke L, Mayosi BM,. Echocardiographic screening for subclinical rheumatic heart disease remains a research tool pending studies of impact on prognosis. Curr. Cardiol. Rep. 2013; 15: 343-349.
12. Spinetto H, Lennon D, Horsburgh M,. Rheumatic fever recurrence prevention: a nurse-led programme of 28-day penicillin in an area of high endemnicity. J. Paediatr. Child Health 2011; 47: 228-234.
13. Powell R, Pattison HM, Bhoyar A, et al. Pulse oximetry screening for congenital heart defects in newborn infants: an evaluation of acceptability to mothers. Arch. Dis. Child. Fetal Neonatal Ed. 2013; 98: F59-63.
14. Asif IM, Johnson S, Schmieg J, et al. The psychological impact of cardiovascular screening: the athlete's perspective. Br. J. Sports Med. 2014; 48: 1162-1166.
15. Solberg EE, Bjornstad TH, Andersen TE, Ekeberg O,. Cardiovascular pre-participation screening does not distress professional football players. Eur. J. Prev. Cardiol. 2012; 19: 571-577.
16. Wark EK, Hodder YC, Woods CE, Maguire GP,. Patient and health-care impact of a pilot rheumatic heart disease screening program. J. Paediatr. Child Health 2013; 49: 297-302.
17. Gemmill AW, Leigh B, Ericksen J, Milgrom J,. A survey of the clinical acceptability of screening for postnatal depression in depressed and non-depressed women. BMC Public Health 2006; 6: 211.
18. Zuckerbrot RA, Maxon L, Pagar D, Davies M, Fisher PW, Shaffer D,. Adolescent depression screening in primary care: feasibility and acceptability. Pediatrics 2007; 119: 101-108.
19. Tluczek A, Koscik RL, Farrell PM, Rock MJ,. Psychosocial risk associated with newborn screening for cystic fibrosis: parents' experience while awaiting the sweat-test appointment. Pediatrics 2005; 115: 1692-1703.
20. VandeKieft GK,. Breaking bad news. Am. Fam. Physician 2001; 64: 1975-1978.
21. DeLuca JM, Kearney MH, Norton SA, Arnold GL,. Parents' experiences of expanded newborn screening evaluations. Pediatrics 2011; 128: 53-61.
22. Bhaya M, Beniwal R, Panwar S, Panwar RB,. Two years of follow-up validates the echocardiographic criteria for the diagnosis and screening of rheumatic heart disease in asymptomatic populations. Echocardiography 2011; 28: 929-933.
23. Paar JA, Berrios NM, Rose JD, et al. Prevalence of rheumatic heart disease in children and young adults in Nicaragua. Am. J. Cardiol. 2010; 105: 1809-1814.
24. Saxena A, Ramakrishnan S, Roy A, et al. Prevalence and outcome of subclinical rheumatic heart disease in India: the RHEUMATIC (Rheumatic Heart Echo Utilisation and Monitoring Actuarial Trends in Indian Children) study. Heart 2011; 97: 2018-2022.
25. Saxena A, Zühlke L, Wilson N,. Echocardiographic screening for rheumatic heart disease: Issues for the cardiology community. Glob. Heart 2013; 8: 197-202.